Welcome to LookChem.com Sign In|Join Free
  • or
1-(Triisopropylsilyloxy)cyclopropylmethanol, with the CAS number 205756-60-1, is a compound that is characterized as a colorless oil. It is primarily utilized in the field of organic synthesis due to its unique chemical properties.

205756-60-1

Post Buying Request

205756-60-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

205756-60-1 Usage

Uses

Used in Organic Synthesis:
1-(Triisopropylsilyloxy)cyclopropylmethanol is used as a synthetic building block for the creation of various organic compounds. Its application in this field is due to its unique reactivity and the ability to form a wide range of products through different chemical reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(Triisopropylsilyloxy)cyclopropylmethanol is used as a key intermediate in the synthesis of certain drugs. Its role in this industry is attributed to its capacity to be transformed into biologically active molecules with potential therapeutic applications.
Used in Chemical Research:
1-(Triisopropylsilyloxy)cyclopropylmethanol is also employed in chemical research as a model compound to study various reaction mechanisms and to develop new synthetic methodologies. Its use in this context is due to its versatile structure and the insights it can provide into the behavior of similar compounds under different reaction conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 205756-60-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,7,5 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 205756-60:
(8*2)+(7*0)+(6*5)+(5*7)+(4*5)+(3*6)+(2*6)+(1*0)=131
131 % 10 = 1
So 205756-60-1 is a valid CAS Registry Number.

205756-60-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name [1-tri(propan-2-yl)silyloxycyclopropyl]methanol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:205756-60-1 SDS

205756-60-1Relevant academic research and scientific papers

Experimental and Computational Studies on Rh(I)-Catalyzed Reaction of Siloxyvinylcyclopropanes and Diazoesters

Feng, Sheng,Wang, Kang,Ping, Yifan,Wang, Jianbo

supporting information, p. 21032 - 21039 (2020/12/21)

The Rh(I)-catalyzed reaction of siloxyvinylcyclopropanes and diazoesters leads to the formation of siloxyvinylcyclobutane and 1,4-diene derivatives. With [Rh(cod)Cl]2 as the catalyst, the formation of 1,4-diene was favored over the formation of siloxyvinylcyclobutane. By changing the catalyst to [Rh(cod)2OTf], siloxyvinylcyclobutane derivatives are formed with excellent chemoselectivities and in moderate to good yields. The alkene products are also obtained as single E configured isomers. A detailed mechanism for this transformation is proposed on the basis of mechanistic experiments and DFT calculations. The effect of catalysts on the chemoselectivity of these reactions is also examined computationally.

Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz

Markwalder, Jay A.,Christ, David D.,Mutlib, Abdul,Cordova, Beverly C.,Klabe, Ronald M.,Seitz, Steven P.

, p. 619 - 622 (2007/10/03)

Studies on the biotransformation of the clinically important non-nucleoside reverse transcriptase inhibitor efavirenz have shown that oxidation and secondary conjugation are important components of the processing of this molecule in vivo. We have synthesized metabolites of efavirenz to confirm their structure and to evaluate their activity as antivirals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 205756-60-1